A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C.

Saved in:
Bibliographic Details
Title: A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C.
Authors: You BC; Department of Internal Medicine, Soon Chun Hyang University Bucheon Hospital, Soon Chun Hyang University College of Medicine, Bucheon, Korea., Kim YS, Kim Hi, Kim SH, Park SS, Seo YR, Kim SG, Lee SW, Kim HS, Jeong SW, Jang JY, Kim BS
Source: Clinical and molecular hepatology [Clin Mol Hepatol] 2012 Sep; Vol. 18 (3), pp. 272-8. Date of Electronic Publication: 2012 Sep 25.
Publication Type: Journal Article
Journal Info: Publisher: Korean Association for the Study of the Liver Country of Publication: Korea (South) NLM ID: 101586730 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2287-285X (Electronic) Linking ISSN: 22872728 NLM ISO Abbreviation: Clin Mol Hepatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2287-285X
DOI:10.3350/cmh.2012.18.3.272